Cetuximab (Erbitux) Infusion Kit from Japan
Cetuximab (Erbitux) is a chimeric monoclonal antibody against EGFR, used for treating colorectal cancer. It is supplied as an infusion kit with measured doses for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This product regulates tumor immunology through EGFR inhibition.
Duty Rate — Japan → Canada
0%
Import Tips
• Verify the infusion kit is in retail packaging with measured doses
• Have the product monograph and batch records ready for CBSA
• Confirm if a Notice of Compliance is required from Health Canada